U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Protein
Created
by admin
on Sat Dec 16 11:46:06 UTC 2023
Edited
by admin
on Sat Dec 16 11:46:06 UTC 2023
Protein Sub Type
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
V23K99CV7G
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MUSCARINIC ACETYLCHOLINE RECEPTOR M1
Common Name English
CHRM1
Common Name English
acetylcholine receptor, muscarinic 1
Common Name English
M1
Common Name English
Code System Code Type Description
PHAROS
P11229
Created by admin on Sat Dec 16 11:46:08 UTC 2023 , Edited by admin on Sat Dec 16 11:46:08 UTC 2023
PRIMARY
FDA UNII
V23K99CV7G
Created by admin on Sat Dec 16 11:46:08 UTC 2023 , Edited by admin on Sat Dec 16 11:46:08 UTC 2023
PRIMARY
UNIPROT
P11229
Created by admin on Sat Dec 16 11:46:08 UTC 2023 , Edited by admin on Sat Dec 16 11:46:08 UTC 2023
PRIMARY
From To
1_98 1_178
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_2
N 1_12
Related Record Type Details
Structure of HTL-9936
AGONIST -> TARGET
full agonist; pERK1/2
EC50
Structure of IMIDAFENACIN
INHIBITOR -> TARGET
Structure of GLYCOPYRROLATE
INHIBITOR -> TARGET
Ki
Structure of TAZOMELINE
AGONIST -> TARGET
Structure of LLNL-02
ACTIVATOR -> TARGET
Promising, novel CNS-permeable oxime ACHE reactivator.
Structure of VEDACLIDINE
INHIBITOR -> TARGET
Structure of TOLTERODINE
INHIBITOR -> TARGET
Structure of PIRENZEPINE
INHIBITOR -> TARGET
Pirenzepine is a selective muscarinic M1 receptor antagonist
Structure of CYCLOPENTOLATE
INHIBITOR -> TARGET
Structure of [3H]Pirenzepine
RADIOLIGAND->TARGET
Kd
Structure of SUCCINYLCHOLINE
AGONIST -> TARGET
Structure of ACOTIAMIDE
INHIBITOR -> TARGET
Structure of TRIHEXYPHENIDYL
INHIBITOR -> TARGET
Structure of AZD-6088
PARTIAL AGONIST->TARGET
Structure of XANOMELINE
AGONIST -> TARGET
Structure of Aroxybutynin
INHIBITOR -> TARGET
Structure of NERATINIB
INHIBITOR->OFF-TARGET
Radioligand binding assay
BINDING
IC50
Structure of ACLIDINIUM
INHIBITOR -> TARGET
Ki
Structure of AF-DX-384
INHIBITOR -> TARGET
Kd
Structure of THRX-195518
INHIBITOR -> TARGET
THRX-195518 possesses activity at target muscarinic receptors that was slightly lower (approximately one-third to one-tenth) than revefenacin.
BINDING
Ki
Structure of SOLIFENACIN
INHIBITOR -> TARGET
Ki
Structure of TAK-071
POSITIVE ALLOSTERIC MODULATOR->TARGET
Structure of Pilocarpine
AGONIST -> TARGET
Structure of MILAMELINE
AGONIST -> TARGET
Structure of PALIPERIDONE
NON-INHIBITOR->OFF TARGET
NON-INHIBITOR
Ki
Structure of TALSACLIDINE
AGONIST -> TARGET
Structure of REVEFENACIN
INHIBITOR -> TARGET
BINDING
Kd
Structure of CARBACHOL
AGONIST -> TARGET
Structure of Oxybutynin
INHIBITOR -> TARGET
Structure of NERATINIB
INHIBITOR->OFF-TARGET
DOXEPIN
INHIBITOR -> TARGET
Structure of SABCOMELINE
PARTIAL AGONIST->TARGET
Structure of REVATROPATE
INHIBITOR -> TARGET
Structure of RISPERIDONE
NON-INHIBITOR->OFF TARGET
Ki
Structure of NORQUETIAPINE
INHIBITOR -> TARGET
Ki
Structure of ALVAMELINE
PARTIAL AGONIST->TARGET
Structure of REVOSIMELINE
AGONIST -> TARGET
Structure of CEVIMELINE
AGONIST -> TARGET
Structure of METHOCTRAMINE FREE BASE
INHIBITOR -> TARGET
BINDING
IC50
Structure of BLARCAMESINE
MODULATOR->TARGET
Structure of ATROPINE
INHIBITOR -> TARGET
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966